European Commission makes further changes to Directive on Information to Patients

If you are interested in the EU Directive on Information to Patients, known colloquially in La Grande Place as 2001/83/EC, then this article from InPharm which went online this afternoon will get you up to speed with the latest changes made by the European Commission.

The most significant of the three recent changes seems to be that health professionals who present information on drugs on behalf of pharma companies should declare what they have been paid and by whom.

I have not been following the Directive that closely I am afraid – I think the EU legislative process has been deliberately designed on the basis that people will lose the will after a certain length of time.  However, the underlying debate as it has travelled through its various stages has been how to ensure the EU does not go the ‘direct-to-consumer’ route as seen in the US.

About these ads

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: